Ali, Ayad K <br/><br/>
Pharmacovigilance Assessment of Immune-Mediated Reactions Reported for Checkpoint Inhibitor Cancer Immunotherapies.  [electronic resource] 

 -  Pharmacotherapy  Nov 2017 
 - 1383-1390 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1875-9114 
<br/><br/><label>Standard No.: </label>10.1002/phar.2035  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antibodies, Monoclonal--administration & dosage<br/>Antibodies, Monoclonal, Humanized--administration & dosage<br/>Antineoplastic Agents--administration & dosage<br/>Bayes Theorem<br/>Female<br/>Humans<br/>Immunotherapy--adverse effects<br/>Ipilimumab--administration & dosage<br/>Male<br/>Middle Aged<br/>Neoplasms--drug therapy<br/>Nivolumab<br/>Pharmacovigilance<br/>Retrospective Studies<br/>Young Adult